Abstract
Cardiomyocyte apoptosis has now been identified in a wide variety of patients with heart failure as well as in failing hearts due to experimentally induced pathophysiological situations such as myocardial infarction, hemodynamic alterations, and different types of cardiomyopathies. Several mechanisms including oxidative stress, inflammation and intracellular Ca2+-overload have been suggested to induce the release of cytotoxic proteins such as cytochrome C for the activation of caspases -3/-9 and subsequent occurrence of apoptotic cell death. Extensive research has revealed both the up-regulation of pro-apoptotic pathway involving PKC isoforms -α/-ε, NFκB, p38-MAPK and BAX, and down-regulation of anti-apoptotic pathway involving Akt, BAD, Bcl-2 and Erk-1/2 in cardiomyocytes from failing hearts. In view of the critical role of inflammation in heart failure, some evidence has been presented to show the role of TNF-α in the activation and deactivation of cell survival and cell death signal transduction pathways for the occurrence of apoptosis in non-ischemic failing hearts due to volume overload and dilated cardiomyopathy. Although the occurrence of apoptosis in failing hearts can be seen to produce loss of some cardiomyocytes leading to heart dysfunction, no meaningful conclusion can be made regarding the exact role of apoptosis in contractile defects during the development of heart failure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Narula J, Haider N, Virmani R et al (1996) Apoptosis in myocytes in end-stage heart failure. N Eng J Med 335:1182–1189
Olivetti G, Abbi R, Quaini F et al (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131–1141
Anversa PL, Kajstura J, Guerra S, Beltrami CA (1998) Myocyte death and growth in the failing heart. Lab Invest 78:767–786
Narula J, Pandey P, Arbustini E et al (1999) Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96:8144–8149
Condorelli G, Morisco C, Stassi G et al (1999) Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes Bax and Bcl-2 during left ventricular adaptation to chronic pressure overload in the rat. Circulation 99:3071–3078
Saraste A, Pulkki K, Kallajoki M et al (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29:380–386
Frustaci A, Chimenti C, Setoguchi M et al (1999) Cell death in acromegalic cardiomyopathy. Circulation 99:1426–1434
Heling A, Zimmermann R, Kostin S et al (2000) Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 86:846–853
Hojo Y, Saito T, Kondo H (2012) Role of apoptosis in left ventricular remodeling after acute myocardial infarction. J Cardiol 60:91–92
Arbustini E, Brega A, Narula J (2008) Ultrastructural definition of apoptosis in heart failure. Heart Fail Rev 13:121–135
Dorn GW II (2009) Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81:465–473
Lee Y, Gustafsson AB (2009) Role of apoptosis in cardiovascular disease. Apoptosis 14:536–548
Philipp S, Pagel I, Hohnel K et al (2004) Regulation of caspase 3 and Fas in pressure overload-induced left ventricular dysfunction. Eur J Heart Fail 6:845–851
Regula KM, Kirshenbaum LA (2005) Apoptosis of ventricular myocytes: a means to an end. J Mol Cell Cardiol 38:3–13
Dent MR, Tappia PS, Dhalla NS (2010) Gender differences in apoptotic signaling in heart failure due to volume overload. Apoptosis 15:499–510
Dent MR, Das S, Dhalla NS (2007) Alterations in both death and survival signals for apoptosis in heart failure due to volume overload. J Mol Cell Cardiol 43:726–732
Das S, Babick AP, Xu YJ et al (2010) TNF-alpha-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy. J Cell Mol Med 14:1988–1997
Kanoh M, Takemura G, Misao J et al (1999) Significance of myocytes with positive DNA end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Circulation 99:2757–2764
Schaper J, Elsasser A, Kostin S (1999) The role of cell death in heart failure. Circ Res 85:867–869
Kang PM, Izumo S (2000) Apoptosis and heart failure: a critical review of the literature. Circ Res 86:1107–1113
Elsasser A, Suzuki K, Schaper J (2000) Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 32:711–724
Knaapen MW, Davies MJ, De Bie M et al (2001) Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51:304–312
Takemura G, Fujiwara H (2006) Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 10:56–75
Sanchis D, Llovera M, Ballester M, Comella JX (2008) An alternative view of apoptosis in heart development and disease. Cardiovasc Res 77:448–451
Cristobal C, Segovia J, Alonso-Pulpon LA et al (2010) Apoptosis and acute cellular rejection in human heart transplants. Rev Esp Cardiol 63:1061–1069
Vahasilta T, Malmberg M, Saraste A et al (2011) Cardiomyocyte apoptosis after antegrade and retrograde cardioplegia during aortic valve surgery. J Thorac Cardiovasc Surg 92:1351–1357
Khoynezhad A, Jalali Z, Tortolani AJ (2007) A synopsis of research in cardiac apoptosis and its application to congestive heart failure. Tex Heart Inst J 34:352–359
Gelpi RJ, Park M, Gao S et al (2011) Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function. Am J Physiol Heart Circ Physiol 300: H1062–H1068
Kolpakov MA, Seqqat R, Rafiq K et al (2009) Pleiotropic effects of neutrophils on myocyte apoptosis and left ventricular remodeling during early volume overload. J Mol Cell Cardiol 47:634–645
Fiorillo C, Nediani C, Ponziani V et al (2005) Cardiac volume overload rapidly induces oxidative stress-mediated myocyte apoptosis and hypertrophy. Biochim Biophys Acta 1741:173–182
Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological action and prevented cell death. Br J Cancer 26:239–257
Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251–306
Searle J, Kerr JFR, Bishop CJ (1982) Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu 17:229–259
Arends MJ, Wyllie AH (1991) Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32:223–254
Alter P, Jobmann M, Meyer E et al (2001) Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study. Cardiovasc Pathol 10:229–234
Krijnen PAJ, Nijmeijer R, Meijer CJL et al (2002) Apoptosis in myocardial ischaemia and infarction. J Clin Pathol 55:801–811
Hughes SE (2003) Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? J Pathol 201:181–186
Nagata S (1997) Apoptosis by death factor. Cell 88:355–365
Green DR, Llambi F (2015) Cell death signaling. Cold Spring Harb Perspect Biol 7:1–24
Takemura G, Kanamori H, Okada H et al (2018) Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration. Heart Fail Rev 23:759–772
Shekhar A, Heeger P, Reutelingsperger C et al (2018) Targeted imaging for cell death in cardiovascular disorders. JACC Cardiovasc Imaging 11:476–493
Jiang X, Guo CX, Zeng XJ et al (2015) A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathway. Apoptosis 20:1033–1047
Gogiraju R, Xu X, Bochenek ML et al (2015) Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice. J Am Heart Assoc 4:1–21
Benjamin EJ, Blaha MJ, Chiuve SE et al (2017) Heart disease and stroke statistics-2017 update: a report from the American heart association. Circulation 135:146–603
Foex P (2017) Innovations in management of cardiac disease: drugs, treatment strategies and technology. Br J Anaesth 119:23–33
Taylor CJ, Ryan R, Nichols L et al (2017) Survival following a diagnosis of heart failure in primary care. Fam Pract 34:161–168
Bennett MR (2002) Apoptosis in the cardiovascular system. Heart 87:480–487
Nishida K, Otsu K (2008) Cell death in heart failure. Circ J 72:17–21
Haudek SB, Taffet GE, Schneider MD et al (2007) TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117:2692–2701
Haunstetter A, Izumo S (1998) Apoptosis basic mechanisms and implications for cardiovascular disease. Circ Res 82:1111–1128
Torre-Amione G, Kapadia S, Lee J et al (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711
Baldi A, Abbate A, Bussani R et al (2002) Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34:165–174
Chang W, Kajstura J, Nitahara JA et al (1996) Programmed cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316–327
Moorjani N, Westaby S, Narula J et al (2009) Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure. Am J Cardiol 103:1261–1268
Cesselli D, Jakoniuk I, Barlucchi L et al (2001) Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89:279–286
Salvesen GS, Dixit VM (1997) Caspases: intracellular signaling by proteolysis. Cell 91:443–446
Black SC, Huang JQ, Rezaiefar P et al (1998) Co-Localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in rats. J Mol Cell Cardiol 30:733–742
Kirshenbaum LA, Meissac D (1997) The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96:1580–1585
Feuerstein GZ (1999) Apoptosis in cardiac diseases-new opportunities for novel therapeutics for heart diseases. Cardiovasc Drugs Ther 13:289–294
Carlson DL, Willis MS, White J et al (2005) Tumor necrosis factor-α-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit Care Med 33:1021–1028
Zell R, Geck P, Werdan K, Boekstegers P (1997) TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function. Mol Cell Biochem 177:61–67
Comstock KL, Krown KA, Page MT et al (1998) LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol 30:2761–2775
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132–1136
Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513–519
Murphy E, Imahashi K, Steenbergen C (2005) Bcl-2 regulation of mitochondrial energetics. Trends Cardiovasc Med 15:283–290
Das S, Tosaki A, Bagchi D et al (2005) Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and—independent pathways. J Pharmacol Exp Ther 314:762–769
Das S, Cordis GA, Maulik N, Das DK (2005) Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol 288:H328–H335
Krown KA, Page MT, Nguyen C et al (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98:2854–2865
Engel D, Peshock R, Armstong RC et al (2004) Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol 287:H1303–H1311
Orogo AM, Gustafsson AB (2013) Cell death in the myocardium: my heart won’t go on. IUBMB Life 65:651–656
Mughal W, Dhingra R, Kirshenbaum LA (2012) Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart. Curr Hypertens Rep 14:540–547
Hofstra L, Liem IH, Dumont EA et al (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356:209–212
Kostin S, Pool L, Elsasser A et al (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92:715–724
Glumac S, Pejic S, Kostadinovic S et al (2016) Apoptosis in endomyocardial biopsies from patients with dilated cardiomyopathy. Folia Biol (Praha) 62:207–211
Chen C, Zou LX, Lin QY et al (2019) Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biol 20:390–401
Liu JJ, Peng L, Bradley CJ et al (2000) Increased apoptosis in the heart of genetic hypertension, associated with increased fibroblasts. Cardiovasc Res 45:729–735
Nishigaki K, Minatoguchi S, Seishima M et al (1997) Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 29:1214–1220
Chao W, Shen Y, Li L et al (2002) Importance of FADD signaling in serum-deprivation- and hypoxia-induced cardiomyocyte apoptosis. J Biol Chem 277:31639–31645
Grazette LP, Rosenzweig A (2005) Role of apoptosis in heart failure. Heart Fail Clin 1:251–261
Zhang X, Szeto C, Gao E et al (2013) Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling. Circ Res 112:498–509
Chen YW, Pat B, Gladden JD et al (2011) Dynamic molecular and histopathological changes in the extracellular matrix and inflammation in the transition to heart failure in isolated volume overload. Am J Physiol Heart Circ Physiol 300:H2251–H2260
Treskatsch S, Shakibaei M, Feldheiser A et al (2015) Ultrastructural changes associated with myocardial apoptosis, in failing rat hearts induced by volume overload. Int J Cardiol 197:327–332
Mohamed BA, Elkenani M, Jakubiczka-Smorag J et al (2019) Genetic deletion of calcium/calmodulin-dependent protein kinase type II delta does not mitigate adverse myocardial remodeling in volume-overloaded hearts. Sci Rep 9:9889
Mohamed BA, Schnelle M, Khadjeh S et al (2016) Molecular and structural transition mechanisms in long-term volume overload. Eur J Heart Fail 18:362–371
Reddy S, Zhao M, Hu DQ et al (2013) Physiologic and molecular characterization of a murine model of right ventricular volume overload. Am J Physiol Heart Circ Physiol 304:H1314–H1327
Aboryag NB, Mohamed DM, Dehe L et al (2017) Histopathological changes in the kidney following congestive heart failure by volume overload in rats. Oxid Med Cell Longev 1–10:2017
Shaqura M, Mohamed DM, Aboryag NB et al (2017) Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats. PLoS One 12:e0184161
Wencker D, Chandra M, Nguyen K et al (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497–1504
Harvey PA, Leinwand LA (2011) The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol 194:355–365
Gu G, Na Y, Chung H et al (2017) Zebrafish larvae model of dilated cardiomyopathy induced by terfenadine. Korean Circ J 47:960–969
Weintraub RG, Semsarian C, Macdonald P (2017) Dilated cardiomyopathy. The Lancet 390:400–414
Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of thecardiomyopathies. Circulation 113:1807–1816
Hantson P (2019) Mechanisms of toxic cardiomyopathy. Clin Toxicol (Phila) 57:1–9
Sakamoto A, Ono K, Abe M et al (1997) Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94:13873–13878
Mitsuhashi S, Saito N, Watano K et al (2003) Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster. J Biochem 134:269–276
Takagi C, Urasawa K, Yoshida I et al (1999) Enhanced GRK5 expression in the hearts of cardiomyopathic hamsters, J2N-k. Biochem Biophys Res Commun 262:206–210
Zorc M, Vraspir-Porenta O, Zorc-Pleskovic R et al (2003) Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. Cardiovasc Pathol 12:36–39
Jain M, Jakubowski A, Cui L et al (2009) A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 119:2058–2068
Wu B, Li J, Ni H et al (2018) TLR4 Activation promotes the progression of experimental autoimmune myocarditis to dilated cardiomyopathy by inducing mitochondrial dynamic imbalance. Oxid Med Cell Longev 3181278
Chen SN, Lombardi R, Karmouch J et al (2019) DNA damage response/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A/C) mutations. Circ Res 124:856–873
Das DK (2003) Protein kinase C isozymes signaling in the heart. J Mol Cell Cardiol 35:887–889
Wang J, Liu X, Arneja AS et al (1999) Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy. Can J Cardiol 15:683–690
Valen G, Yan ZQ, Hansson GK (2001) Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307–314
Badrichani AZ, Stroka DM, Bilbao G et al (1999) Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest 103:543–553
Cook SA, Sugden PH, Clerk A (1999) Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 31:1429–1434
Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776–781
Yang E, Zha J, Jockel J et al (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl2, displaces Bax and promotes cell death. Cell 80:285–291
Scheid MP, Duronio V (1998) Dissociation of cytokine-induced phosphorylation of BAD and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc Natl Acad Sci USA 95:7439–7444
Cardone MH, Roy N, Stennicke HR et al (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321
Nicolson WD, Thornberry NA (1997) Caspases: killer proteases. Trends Biochem Sci 257:299–306
Ruvolo PP, Deng X, May WS (2001) Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15:515–522
Saini HK, Xu Y-J, Zhang M et al (2005) Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart. Exp Clin Cardiol 10:213–222
Zhang M, Xu Y-J, Saini HK et al (2005) TNF alpha as a potential mediator of cardiac dysfunction due to intracellular Ca2+-overload. Biochem Biophys Res Commun 327:57–63
Sack M (2002) Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol Ther 94:123–135
Acknowledgements
The infrastructure support for this project was provided by the St. Boniface Hospital Research Foundation, Winnipeg, Canada.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bhullar, S.K., Shah, A.K., Dhalla, N.S. (2022). Role of Cardiomyocyte Apoptosis in Heart Failure. In: Kirshenbaum, L.A. (eds) Biochemistry of Apoptosis and Autophagy. Advances in Biochemistry in Health and Disease, vol 18. Springer, Cham. https://doi.org/10.1007/978-3-030-78799-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-78799-8_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78798-1
Online ISBN: 978-3-030-78799-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)